Department of Oral and Maxillofacial Surgery, School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Oral and Maxillofacial Surgery, Sorasky Medical Center, Tel Aviv, Israel.
Clin Oral Investig. 2021 Mar;25(3):1001-1009. doi: 10.1007/s00784-020-03389-z. Epub 2020 Jun 6.
To present our experience treating patients who have undergone dental implantation under no change in their constant anticoagulant treatment.
A retrospective study on patients who have undergone dental implantation. The study group consisted of patients under oral anticoagulants for at least 6 months before dental implantation. The control group was consisted of healthy patients with no oral anticoagulant treatment. Bleeding events were recorded and treated during the first 2 weeks postoperatively.
A total of 193 patients were included in the study. Seventy-two of them who were under anticoagulants served as a study group and the rest (121 patients) served as a control group. Mean age: 65 years old in the study group and 59 years old in the control group. Gender: male to female ratio was higher in the study group and lower in the control group. Four patients in the study group and 7 patients in the control group presented postoperative bleeding and were treated successfully by additional local hemostasis methods.
With the limitation of this study, it can be concluded that patients under oral anticoagulant treatment can undergo dental implantation safely. Bleeding events are rare and can be controlled by local hemostasis.
Prior to dental implant insertion, patients under oral anticoagulants can continue their constant medical treatment. The procedure can be performed on outpatient basis under local hemostasis.
介绍我们在患者持续使用抗凝药物治疗不变的情况下进行牙科种植的经验。
这是一项针对接受过牙科种植的患者的回顾性研究。研究组由至少在牙科种植前 6 个月开始接受口服抗凝治疗的患者组成。对照组由未接受口服抗凝治疗的健康患者组成。记录并在术后 2 周内治疗出血事件。
共有 193 名患者入组。其中 72 名接受抗凝治疗的患者作为研究组，其余 121 名患者作为对照组。平均年龄：研究组为 65 岁，对照组为 59 岁。性别：研究组的男女比例较高，对照组较低。研究组中有 4 名患者和对照组中有 7 名患者出现术后出血，并通过额外的局部止血方法成功治疗。
受本研究的限制，可以得出结论，接受口服抗凝治疗的患者可以安全地进行牙科种植。出血事件很少见，可以通过局部止血来控制。
在进行牙科种植之前，接受口服抗凝治疗的患者可以继续接受常规的药物治疗。该手术可以在门诊基础上进行，并采用局部止血。
